Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:17:39.195Z.
Calculation as of: 2026-10-06T19:17:39.195Z.
Quote observation: 2026-10-06T19:15:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 65e01e2061821370315a71c231e2ba412a336584d38d2dbcbde0d0d1c3e2cd16
EARNINGS YIELD
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$300.57M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$292.45M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$309.19M
Earnings Yield
N/A
TTM Avg
4.04%
3Y Avg
4.04%
5Y Avg
4.04%
Market Cap
$287.63M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$286.02M
Earnings Yield
N/A
TTM Avg
17.53%
3Y Avg
17.53%
5Y Avg
17.53%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $300.57M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $292.45M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | N/A | 4.04% | 4.04% | 4.04% |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.46M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $287.63M | N/A | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $287.24M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $314.40M | 35.04% | 39.56% | 39.56% | 24.80% |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.02M | N/A | 17.53% | 17.53% | 17.53% |
| Aurora Cannabis Inc. (ACB)vs › | $283.08M | N/A | 3.82% | 3.82% | 3.82% |
| Standard BioTools Inc. (LAB)vs › | $283.07M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
